7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

We are 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid CAS:86393-33-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 86393-33-1
Product Name: 7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
Other Name:
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
 
Density: 1.7±0.1 g/cm3
Boiling Point: 467.3±45.0 °C at 760 mmHg
Melting Point: 242-245 °C(lit.)
Molecular Formula: C13H9ClFNO3
Molecular Weight: 281.667
Flash Point: 236.4±28.7 °C
Exact Mass: 281.025513
PSA: 59.30000
LogP: 2.16
Vapour Pressure: 0.0±1.2 mmHg at 25°C
Index of Refraction: 1.683
Storage condition: -20°C Freezer
 
Specification
Appearance: Yellow or light yellow powder
Assay(HPLC): ≥99.0%
Methyl Ester: ≤0.2%
Unknown largest single impurity: ≤0.5%
Total impurities: ≤1.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Ciprofloxacin CAS: 85721-33-1.
Be used as intermediate for the new quinoline antibacterial drug ciprofloxacin.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid


Related News: Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.2,2-Difluoro-1,3-benzodioxole CAS:1583-59-1 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.1591-31-7 After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.2,4-Dichloro-1-(2-propynyloxy)benzene CAS:17061-90-4 Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.

Related Products
Product Name
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid View Details
2-Bromo-1-(3-nitrophenyl)ethanone View Details
Goserelin acetate View Details
Methyl 4-[(5-amino-1-methylindol-3-yl)methyl]-3-methoxybenzoate manufacturer L-Citrulline manufacturer {4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol manufacturer 2-chloro-5-(trifluoromethyl)benzene-1,3-diamine manufacturer Caffeic acid manufacturer